For the treatment of adults with mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the following designated microorganisms in the infections listed.
Acute bacterial exacerbations of chronic bronchitis: Due to Haemophilus influenza or Streptococcus pneumonia.
Acute pelvic inflammatory disease (including severe infection): Due to Chlamydia trachomatis and/or Neisseria gonorrhoeae.
Acute, uncomplicated urethral and cervical gonorrhea: Due to N. gonorrhoeae.
Community-acquired pneumonia: Due to H. influenza or S. pneumonia.
Complicated urinary tract infections: Due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Citrobacter diversus, or Pseudomonas aeruginosa. Although treatment of infections due to C. diversus and P. aeruginosa in this organ system demonstrated a clinically significant outcome, efficacy was studied in fewer than 10 patients.
Mixed infections of the urethra and cervix: Due to C. trachomatis and N. gonorrhoeae.
Nongonococcal urethritis and cervicitis: Due to C. trachomatis.
Prostatitis: Due to E. coli.
Uncomplicated cystitis: Due to C. diversus, Enterobacter aerogenes, E. coli, K. pneumonia, P. mirabilis, or P. aeruginosa.
Uncomplicated skin and skin structure infections: Due to Staphylococcus aureus (methicillin-susceptible), S. pyogenes, or P. mirabilis.